| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 121.74 | 59.84 | 46.59 | 10.41 |
| Net Changein Cash | 97.73 | 7.05 | -3.11 | 1.58 |
| Cash Taxes Paid | 9.17 | 2.49 | 1.45 | 0.14 |
| Net Income/ Starting Line | 70.57 | 24.94 | 12.44 | 1.14 |
| Changesin Working Capital | -125.54 | -60.67 | -15.97 | -12.25 |
| Cashfrom Operating Activities | -45.92 | -25.70 | -1.08 | -10.45 |
| Cash Interest Paid | 20.36 | 8.50 | 1.84 | 0.51 |
| Cashfrom Financing Activities | 573.13 | 86.98 | 46.25 | 36.46 |
| Issuance( Retirement)of Stock Net | 15.55 | 36.99 | 1.07 | 4.94 |
| Depreciation/ Depletion | 16.84 | 10.02 | 1.78 | 0.71 |
| Other Investing Cash Flow Items Total | -271.96 | -2.40 | -1.01 | -13.76 |
| Capital Expenditures | -157.52 | -51.83 | -47.28 | -10.68 |
| period Type | - | - | - | - |
| Non- Cash Items | -7.79 | -0.07 | 0.67 | -0.04 |
| Financing Cash Flow Items | 435.84 | -9.85 | -1.41 | 21.11 |
| Deferred Taxes | 0.00 | 0.08 | - | - |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -429.48 | -54.23 | -48.29 | -24.44 |
Senores Pharmaceuticals Dividend Senores Pharmaceuticals Bonus Senores Pharmaceuticals News Senores Pharmaceuticals AGM Senores Pharmaceuticals Rights Senores Pharmaceuticals Splits Senores Pharmaceuticals Board Meetings Senores Pharmaceuticals Key Metrics Senores Pharmaceuticals Shareholdings Senores Pharmaceuticals Profit Loss Senores Pharmaceuticals Balance Sheet Senores Pharmaceuticals Q1 Results Senores Pharmaceuticals Q2 Results Senores Pharmaceuticals Q3 Results Senores Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks